Alzheimer's drug development pipeline: Positive results, new insight on biomarkers position 2024 as 'learning year'
by Steven Slivka, John Domol,University of Nevada, Las VegasDr. Jeffrey Cummings, research professor and director, Chambers-Grundy Center for Transformative Neuroscience at UNLV. Credit: Josh Ha
Updated on: April 28,2024
0
Alzheimer's drug development pipeline: Positive results, new insight on biomarkers position 2024 as 'learning year'
by Steven Slivka, John Domol,University of Nevada, Las VegasDr. Jeffrey Cummings, research professor and director, Chambers-Grundy Center for Transformative Neuroscience at UNLV. Credit: Josh Ha
Updated on:April 28,2024
0